Research is exploring the potential of crispr to improve the safety and scalability of car t cell therapy. Some studies and partnerships are investigating the use of gene editing and cell engineering to enhance the effectiveness of these therapies. The development of new technologies and platforms may help address current limitations and increase access to cell and gene therapies for more patients.